carvedilol has been researched along with ubiquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, M; Harada, M; Hosoda, K; Kawakami, R; Kinoshita, H; Kotani, H; Kuwahara, K; Nakagawa, Y; Nakanishi, M; Nakao, K; Tadamura, E; Ueshima, K; Usami, S | 1 |
| Fujino, M; Higuchi, S; Kadoya, T; Kawakita, R; Kawasaki, Y; Kitayama, K; Koga, Y; Murakami, Y; Murayama, K; Ohtake, A; Okazaki, Y; Sakakibara, A; Shimura, M; Yamada, Y; Yorifuji, T | 1 |
2 other study(ies) available for carvedilol and ubiquinone
| Article | Year |
|---|---|
Images in cardiovascular medicine. Mitochondrial cardiomyopathy evaluated with cardiac magnetic resonance.
Topics: Aged; Biopsy; Carbazoles; Cardiomyopathies; Carvedilol; Coenzymes; Coronary Angiography; Enalapril; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Mitochondria, Heart; Mitochondrial Diseases; Propanolamines; Ubiquinone | 2007 |
Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10.
Topics: Acidosis; Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenases; Adrenergic beta-Antagonists; Amino Acid Metabolism, Inborn Errors; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Carvedilol; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Mitochondrial Diseases; Muscle Weakness; Prognosis; Pyruvates; Ubiquinone; Vitamins | 2019 |